Health authorities are rolling out a vaccination initiative this summer aimed at protecting approximately one million young people against meningitis B. The program targets Year 13 pupils preparing to leave for university and individuals under 25 who are beginning university or residential further education studies in the autumn months. These groups will receive two doses of the MenB vaccine free through the National Health Service.
Meningitis is an infection affecting the protective membranes surrounding the brain and spinal cord. While bacterial forms are rarer than viral variants, they present greater health risks and can progress to blood poisoning or sepsis. Meningococcal disease, which can lead to invasive infections affecting the bloodstream or brain linings, occurs regularly with 378 cases of invasive meningococcal disease documented in the period 2024-2025. Meningitis B accounts for the majority of severe meningococcal disease cases in the UK.
Symptoms of meningitis develop rapidly and may include sudden high fever, severe headache, neck stiffness, rash that does not fade under pressure, vomiting, diarrhea, joint and muscle pain, sensitivity to light, and confusion. In severe cases, seizures and extreme difficulty waking may occur. Young people living in shared accommodation face elevated risk, particularly during peak transmission periods in October and November. The bacteria spreads through close personal contact via respiratory droplets from coughs and sneezes, saliva exchange during kissing, or sharing items like drinks and vaping devices.
Multiple vaccines offer protection against meningitis causes. The MenB vaccine, added to the childhood immunization schedule for babies born from 1 July 2015 onwards, protects against meningococcal group B bacteria. The MenACWY vaccine covers four additional bacterial types and is offered to 14-year-olds. Other vaccines including the six-in-one childhood vaccine, pneumococcal vaccines, and the recently introduced MMRV vaccine provide indirect protection. Vaccine experts recommend governments consider routine MenB vaccination for teenagers around age 15, though individual nations must make these decisions independently.
Any person experiencing meningitis or sepsis symptoms requires urgent medical attention at an emergency department or via emergency services. Early treatment can be life-saving, and antibiotics administered to close contacts help prevent disease transmission.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI